VD

Vivekananda Devi Potabattula

Active Director Director DIN 09253473
DIN 09253473 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Vivekananda Devi Potabattula

Data last updated:

Vivekananda Devi Potabattula is a Director at Relez Pharma Private Limited (since 2021). The company operates in Pharma. Relez Pharma Private Limited reported revenue of ₹1.44 Cr (FY 2025).

DIN 09253473
Primary Designation Director
Industry Pharma
First Appointment 26 Jul 2021
Oldest Company Age 5 yrs
Largest company Relez Pharma Private Limited · ₹1.44 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Relez Pharma Private Limited U24290GJ2021PTC121177
Director26 Jul 20212021₹1.44 Cr (FY 2025)Active

Board colleagues of Vivekananda Devi Potabattula

Directorship timeline

Open interactive timeline →
Relez Pharma Private Limited
Premium access

Shareholding and investment profile for Vivekananda Devi Potabattula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivekananda Devi Potabattula

Vivekananda Devi Potabattula currently holds 1 directorship: Relez Pharma Private Limited (Director, since 26 Jul 2021, revenue ₹1.44 Cr (FY 2025)).

Vivekananda Devi Potabattula was first appointed on 26 Jul 2021 as Director at Relez Pharma Private Limited.

The current boards of Vivekananda Devi Potabattula's companies include Mayuri Bhausaheb Khevare (Relez Pharma Private Limited), Yogesh Subhash Sumbe (Relez Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available